Therapeutic effect of ibrutinib, a selective Bruton’s tyrosine kinase inhibitor, in orbital fibroblasts from patients with Graves’ orbitopathy

PURPOSE: Bruton’s tyrosine kinase (BTK) is an essential protein in B-cell antigen receptor (BCR) signaling pathway and is known to be related to pathogenetic effect on B-cell related malignancies and various autoimmune diseases. In this study, we investigated the therapeutic effect of ibrutinib, an...

Descripción completa

Detalles Bibliográficos
Autores principales: Park, Hyun Young, Chae, Min Kyung, Ko, JaeSang, Kikkawa, Don O., Jang, Sun Young, Yoon, Jin Sook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754806/
https://www.ncbi.nlm.nih.gov/pubmed/36521376
http://dx.doi.org/10.1371/journal.pone.0279060

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9754806/
https://www.ncbi.nlm.nih.gov/pubmed/36521376
http://dx.doi.org/10.1371/journal.pone.0279060

Ejemplares similares